跳至主要内容
临床试验/NCT02581072
NCT02581072已完成1 期

A Double-blind, Double-dummy, Randomized, 4-period Crossover Study to Define the ECG Effects of SB204 Using a Clinical and Supratherapeutic Dose Compared With Placebo and Moxifloxacin in Subjects With Acne Vulgaris: A Thorough ECG STudy

Novan, Inc.1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2015年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Novan, Inc.
入组人数
56
试验地点
1
主要终点
Define ECG effect of SB204 at therapeutic and supratherapeutic dose concentrations as measured by the difference between time-matched baseline adjusted QTcF interval for the groups recieving SB204 and placebo.

研究概览

简要总结

A Double-Blind, Double-Dummy, Randomized, 4-Period Crossover Study to Define the ECG Effects of SB204 Using a Clinical and Supratherapeutic Dose Compared with Placebo and Moxifloxacin (a Positive Control) in Subjects with Acne Vulgaris: A Thorough ECG Study

详细描述

A Double-Blind, Double-Dummy, Randomized, 4-Period, Crossover Study to Define the ECG Effects of SB204 Using a Clinical and a Supratherapeutic Dose Compared with Placebo and Moxifloxacin (a Positive Control) in Subjects with Acne Vulgaris: A Thorough ECG Study

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Moderate to severe acne
  • 20 inflammatory and 25 non-inflammatory acne lesions

排除标准

  • Pregnant, trying to become pregnant, or nursing
  • Known allergy to any component of the topical SB204 formulation

研究组 & 干预措施

SB204 4%

Experimental

SB204 4% once

干预措施: SB204 4% (Drug)

SB204 8% or 12 %

Experimental

SB204 8 or 12 % (supratherapeutic) once

干预措施: SB204 8% or 12% (Drug)

Vehicle Gel

Placebo Comparator

Placebo

干预措施: Vehicle (Drug)

结局指标

主要结局

Define ECG effect of SB204 at therapeutic and supratherapeutic dose concentrations as measured by the difference between time-matched baseline adjusted QTcF interval for the groups recieving SB204 and placebo.

时间窗: 15 days

次要结局

  • Categorical analysis of the QTc interval to determine number and percentage of time points and subjects by dose group with absolute QT/QTc > 450, 480, and 500 ms.(15 days)

研究者

发起方
Novan, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Thorough ECG Study in Subjects With Acne Vulgaris... | 临床试验